Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Recommendation of “Hold” from Brokerages

Pediatrix Medical Group, Inc. (NYSE:MDGet Free Report) has received a consensus rating of “Hold” from the four brokerages that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $10.30.

A number of research analysts recently weighed in on the company. Truist Financial dropped their price target on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating on the stock in a research note on Wednesday, February 21st. Mizuho cut their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Jefferies Financial Group reduced their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Finally, TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a report on Friday, February 23rd.

View Our Latest Stock Report on Pediatrix Medical Group

Pediatrix Medical Group Trading Up 0.4 %

NYSE MD opened at $10.03 on Friday. The stock has a market capitalization of $843.72 million, a P/E ratio of -13.74, a P/E/G ratio of 2.71 and a beta of 1.56. The business has a 50 day simple moving average of $9.25 and a 200 day simple moving average of $10.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. Pediatrix Medical Group has a one year low of $7.70 and a one year high of $15.20.

Pediatrix Medical Group (NYSE:MDGet Free Report) last released its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.02. The company had revenue of $496.44 million during the quarter, compared to analyst estimates of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. Pediatrix Medical Group’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 EPS. Research analysts expect that Pediatrix Medical Group will post 1.12 earnings per share for the current year.

Institutional Trading of Pediatrix Medical Group

A number of institutional investors have recently modified their holdings of the business. Pacer Advisors Inc. boosted its stake in Pediatrix Medical Group by 126.9% in the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after purchasing an additional 1,809,828 shares during the period. Nordea Investment Management AB grew its position in Pediatrix Medical Group by 0.6% during the third quarter. Nordea Investment Management AB now owns 219,561 shares of the company’s stock valued at $2,810,000 after acquiring an additional 1,221 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of Pediatrix Medical Group by 4.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,485,465 shares of the company’s stock valued at $18,880,000 after purchasing an additional 57,193 shares in the last quarter. Invesco Ltd. raised its position in Pediatrix Medical Group by 2.5% in the 3rd quarter. Invesco Ltd. now owns 705,240 shares of the company’s stock worth $8,964,000 after purchasing an additional 16,875 shares during the period. Finally, Envestnet Asset Management Inc. boosted its position in Pediatrix Medical Group by 250.6% during the third quarter. Envestnet Asset Management Inc. now owns 267,434 shares of the company’s stock valued at $3,399,000 after buying an additional 191,154 shares during the period. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

(Get Free Report

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Further Reading

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.